Hunt Anthony
Insider CIK 1606030 · MASS Director · RGEN Chief Operating Officer, Director · BLFS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLFS BIOLIFE SOLUTIONS INC | D To issuer | 2026-10-06 | 2026-10-08 | 15,046 | — | — | 0 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 6,209 | — | $0 | 6,209 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 13,656 | — | $0 | 13,656 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2026-06-10 | 2026-06-12 | 14,083 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2026-06-10 | 2026-06-12 | 14,083 | — | $0 | 44,168 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-03-02 | 2026-03-03 | 9,897 | $124.97 | $1.24M | 89,062 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2026-02-24 | 2026-02-26 | 8,170 | — | $0 | 15,046 | SEC↗ |
| RGEN REPLIGEN CORP | J Other | 2025-12-04 | 2025-12-08 | 2,000 | — | $0 | 98,959 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2025-11-13 | 2025-11-14 | 2,952 | — | $0 | 14,760 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2025-11-13 | 2025-11-14 | 2,952 | $33.87 | $100.0K | 83,695 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 1,956 | $157.11 | $307.3K | 80,743 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 5,737 | $156.22 | $896.2K | 82,699 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 3,000 | $155.45 | $466.3K | 88,436 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 2,500 | $154.32 | $385.8K | 91,436 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 2,923 | $153.14 | $447.6K | 93,936 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 2,100 | $152.17 | $319.6K | 96,859 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-13 | 2025-11-14 | 1,784 | $151.01 | $269.4K | 98,959 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2025-11-12 | 2025-11-13 | 25,000 | — | $0 | 157,344 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-12 | 2025-11-13 | 11,096 | $158.01 | $1.75M | 101,207 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-12 | 2025-11-13 | 464 | $158.51 | $73.5K | 100,743 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-12 | 2025-11-13 | 4,959 | $156.65 | $776.8K | 112,303 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-12 | 2025-11-13 | 4,740 | $155.85 | $738.7K | 117,262 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-12 | 2025-11-13 | 3,741 | $154.92 | $579.6K | 122,002 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2025-11-12 | 2025-11-13 | 25,000 | $33.87 | $846.7K | 125,743 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2025-09-10 | 2025-09-11 | 20,000 | — | $0 | 182,344 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 7,584 | $121.42 | $920.8K | 102,922 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 3,262 | $119.64 | $390.3K | 125,388 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 2,179 | $122.23 | $266.3K | 100,743 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2025-09-10 | 2025-09-11 | 20,000 | $33.87 | $677.4K | 129,854 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 96 | $116.34 | $11.2K | 129,758 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 1,108 | $118.32 | $131.1K | 128,650 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-09-10 | 2025-09-11 | 14,882 | $120.19 | $1.79M | 110,506 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 6,516 | — | $0 | 6,516 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 14,083 | — | $0 | 14,083 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2025-06-11 | 2025-06-13 | 11,364 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2025-06-11 | 2025-06-13 | 11,364 | — | $0 | 30,085 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-05-15 | 2025-05-16 | 6,533 | $124.34 | $812.3K | 110,129 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-05-15 | 2025-05-16 | 268 | $125.20 | $33.6K | 109,861 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-05-15 | 2025-05-16 | 7 | $127.00 | $889 | 109,854 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-05-15 | 2025-05-16 | 17,596 | $123.57 | $2.17M | 116,662 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-05-15 | 2025-05-16 | 2,043 | $122.66 | $250.6K | 134,258 | SEC↗ |
| BLFS BIOLIFE SOLUTIONS INC | A Award | 2025-03-18 | 2025-03-20 | 6,876 | — | $0 | 6,876 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2025-03-17 | 2025-03-19 | 21,756 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2025-03-17 | 2025-03-19 | 5,000 | — | $0 | 202,344 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2025-03-17 | 2025-03-19 | 21,756 | $59.52 | $1.29M | 163,057 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2025-03-17 | 2025-03-19 | 5,000 | $33.87 | $169.3K | 141,301 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 60 | $148.05 | $8.9K | 162,997 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 100 | $150.38 | $15.0K | 162,897 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 2,518 | $151.09 | $380.4K | 160,379 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 6,176 | $151.96 | $938.5K | 154,203 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 15,619 | $152.82 | $2.39M | 138,584 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-03-17 | 2025-03-19 | 2,283 | $153.70 | $350.9K | 136,301 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-03-03 | 2025-03-04 | 10,142 | $155.38 | $1.58M | 136,301 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2025-03-02 | 2025-03-04 | 2,058 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2025-03-02 | 2025-03-04 | 2,058 | — | $0 | 18,721 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-02-27 | 2025-02-28 | 2,825 | $156.54 | $442.2K | 146,443 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-02-24 | 2025-02-25 | 2,380 | $164.74 | $392.1K | 149,268 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-12-05 | 2024-12-05 | 11,808 | — | $0 | 8,856 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-12-05 | 2024-12-05 | 11,808 | $33.87 | $399.9K | 151,648 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-11-21 | 2024-11-22 | 24,246 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-11-21 | 2024-11-22 | 24,246 | $33.87 | $821.2K | 164,086 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-11-21 | 2024-11-22 | 24,246 | $139.67 | $3.39M | 139,840 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-09-10 | 2024-09-12 | 10,000 | — | $0 | 24,246 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-09-10 | 2024-09-12 | 10,000 | $33.87 | $338.7K | 162,031 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-09-10 | 2024-09-12 | 1,495 | $143.77 | $214.9K | 160,536 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-09-10 | 2024-09-12 | 9,369 | $144.88 | $1.36M | 151,167 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-09-10 | 2024-09-12 | 604 | $146.67 | $88.6K | 139,840 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-09-10 | 2024-09-12 | 10,723 | $145.95 | $1.57M | 140,444 | SEC↗ |
| RGEN REPLIGEN CORP | D To issuer deriv | 2024-09-03 | 2024-09-04 | 13,057 | — | $0 | 6,528 | SEC↗ |
| RGEN REPLIGEN CORP | D To issuer | 2024-09-03 | 2024-09-04 | 13,146 | — | $0 | 152,031 | SEC↗ |
| RGEN REPLIGEN CORP | P Buy | 2024-06-14 | 2024-06-14 | 2,000 | $124.08 | $248.2K | 165,177 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 11,364 | — | $0 | 11,364 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 15,996 | — | $0 | 15,996 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2024-06-12 | 2024-06-14 | 7,777 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2024-06-12 | 2024-06-14 | 7,777 | — | $0 | 16,663 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 2,963 | $169.27 | $501.5K | 168,071 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 4,274 | $166.36 | $711.0K | 178,975 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 4,008 | $167.05 | $669.5K | 174,967 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 969 | $171.03 | $165.7K | 163,177 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 3,925 | $170.04 | $667.4K | 164,146 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-05-21 | 2024-05-22 | 3,933 | $168.33 | $662.0K | 171,034 | SEC↗ |
| RGEN REPLIGEN CORP | G Gift | 2024-03-18 | 2024-03-20 | 2,000 | — | $0 | 183,249 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2024-03-08 | 2024-03-11 | 1 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 6,228 | $196.32 | $1.22M | 192,351 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 3,377 | $195.49 | $660.2K | 198,579 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2024-03-08 | 2024-03-11 | 1 | $16.55 | $17 | 201,956 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 1,822 | $199.53 | $363.5K | 187,516 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 1,347 | $198.55 | $267.4K | 189,338 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 1,666 | $197.39 | $328.9K | 190,685 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 1,305 | $200.56 | $261.7K | 186,211 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 156 | $202.55 | $31.6K | 185,249 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2024-03-08 | 2024-03-11 | 806 | $201.75 | $162.6K | 185,405 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-07 | 2024-03-07 | 2,867 | $195.72 | $561.1K | 201,955 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-05 | 2024-03-06 | 7,275 | $195.52 | $1.42M | 204,822 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2024-03-04 | 2024-03-05 | 2,057 | — | $0 | 2,058 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2024-03-04 | 2024-03-05 | 2,057 | — | $0 | 8,886 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-04 | 2024-03-06 | 1,111 | $193.99 | $215.5K | 212,097 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-03-01 | 2024-03-04 | 3,322 | $191.79 | $637.1K | 213,208 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-02-29 | 2024-03-04 | 2,504 | — | $0 | 216,530 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2024-02-27 | 2024-02-29 | 19,585 | — | $0 | 19,585 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-02-27 | 2024-02-29 | 19,719 | — | $0 | 214,026 | SEC↗ |
| RGEN REPLIGEN CORP | G Gift | 2023-11-14 | 2023-11-16 | 1,000 | — | $0 | 194,307 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 7,777 | — | $0 | 7,777 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 12,076 | — | $0 | 12,076 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2023-06-14 | 2023-06-16 | 4,771 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2023-06-14 | 2023-06-16 | 4,771 | — | $0 | 6,829 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-03-03 | 2023-03-06 | 8,244 | $188.00 | $1.55M | 195,307 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-03-03 | 2023-03-06 | 18,584 | — | $0 | 203,551 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2023-03-02 | 2023-03-06 | 20,080 | — | $0 | 20,080 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise deriv | 2023-03-02 | 2023-03-07 | 2,058 | — | $0 | 4,115 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-03-02 | 2023-03-02 | 6,670 | $176.37 | $1.18M | 165,574 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-03-02 | 2023-03-06 | 19,393 | — | $0 | 184,967 | SEC↗ |
| MASS 908 Devices Inc. | M Exercise | 2023-03-02 | 2023-03-07 | 2,058 | — | $0 | 2,058 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-02-28 | 2023-02-28 | 3,273 | $173.44 | $567.7K | 174,992 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2023-02-28 | 2023-03-02 | 2,748 | $173.28 | $476.2K | 172,244 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-11-11 | 2022-11-14 | 25,000 | — | $0 | 34,246 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-11-11 | 2022-11-14 | 25,000 | $200.00 | $5.00M | 178,265 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-11-11 | 2022-11-14 | 25,000 | $33.87 | $846.7K | 203,265 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-09-08 | 2022-09-09 | 10,000 | — | $0 | 59,246 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 824 | $220.08 | $181.3K | 203,843 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 1,235 | $221.46 | $273.5K | 202,608 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-09-08 | 2022-09-09 | 10,000 | $33.87 | $338.7K | 204,667 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 720 | $222.24 | $160.0K | 201,888 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 1,389 | $223.26 | $310.1K | 200,499 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 6,626 | $224.47 | $1.49M | 193,873 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 10,490 | $225.22 | $2.36M | 183,383 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 245 | $227.01 | $55.6K | 178,265 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-09-08 | 2022-09-09 | 4,873 | $226.34 | $1.10M | 178,510 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-07-21 | 2022-07-22 | 15,154 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2022-07-21 | 2022-07-22 | 5,000 | — | $0 | 69,246 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-07-21 | 2022-07-22 | 15,154 | $32.40 | $491.0K | 219,469 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2022-07-21 | 2022-07-22 | 24,802 | $200.00 | $4.96M | 194,667 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2022-07-21 | 2022-07-22 | 5,000 | $33.87 | $169.3K | 204,315 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 7,970 | — | $0 | 7,970 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 4,771 | — | $0 | 4,771 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 10,362 | — | $0 | 10,362 | SEC↗ |
| MASS 908 Devices Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 6,173 | — | $0 | 6,173 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-03-01 | 2022-03-03 | 7,292 | $194.06 | $1.42M | 199,315 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-28 | 2022-03-02 | 13,368 | $196.70 | $2.63M | 206,607 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-28 | 2022-03-02 | 3,170 | $196.70 | $623.5K | 189,901 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-02-28 | 2022-03-02 | 30,074 | — | $0 | 219,975 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-27 | 2022-03-02 | 2,754 | $196.70 | $541.7K | 193,071 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2022-02-24 | 2022-02-28 | 20,307 | — | $0 | 20,307 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2022-02-24 | 2022-02-28 | 15,855 | — | $0 | 196,995 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2022-02-24 | 2022-02-28 | 1,170 | $189.21 | $221.4K | 195,825 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-11-18 | 2021-11-19 | 10,000 | — | $0 | 15,154 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 6,024 | $278.08 | $1.68M | 183,706 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 1,732 | $277.01 | $479.8K | 189,730 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 970 | $279.08 | $270.7K | 182,736 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 596 | $281.40 | $167.7K | 182,140 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 4,017 | $276.20 | $1.11M | 191,462 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-11-18 | 2021-11-19 | 10,000 | $32.40 | $324.0K | 199,495 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 2,061 | $273.91 | $564.5K | 197,434 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-11-18 | 2021-11-19 | 1,955 | $274.83 | $537.3K | 195,479 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2021-09-09 | 2021-09-13 | 25,000 | — | $0 | 25,154 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2021-09-09 | 2021-09-13 | 25,000 | $32.40 | $810.0K | 214,495 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-09 | 2021-09-13 | 8 | $296.58 | $2.4K | 189,495 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-09 | 2021-09-13 | 1,631 | $296.09 | $482.9K | 189,503 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-09 | 2021-09-13 | 14,825 | $294.90 | $4.37M | 191,134 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-09-09 | 2021-09-13 | 8,536 | $294.22 | $2.51M | 205,959 | SEC↗ |
| RGEN REPLIGEN CORP | G Gift | 2021-08-17 | 2021-08-18 | 1,000 | — | $0 | 189,495 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 612 | $168.29 | $103.0K | 212,150 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 2,529 | $169.45 | $428.5K | 209,621 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 7,911 | $170.28 | $1.35M | 201,710 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 3,420 | $171.32 | $585.9K | 198,290 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 3,036 | $172.52 | $523.8K | 195,254 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 1,560 | $173.19 | $270.2K | 193,694 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 2,819 | $174.41 | $491.7K | 190,875 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-05-19 | 2021-05-20 | 380 | $175.15 | $66.6K | 190,495 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 1,081 | $191.19 | $206.7K | 214,602 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 227 | $193.30 | $43.9K | 212,997 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 1,378 | $192.17 | $264.8K | 213,224 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 235 | $194.08 | $45.6K | 212,762 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 4,096 | $190.17 | $778.9K | 215,683 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 1,171 | $188.77 | $221.0K | 219,779 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-12 | 2021-03-12 | 914 | $188.06 | $171.9K | 220,950 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 4,271 | $186.90 | $798.2K | 228,243 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 595 | $187.48 | $111.6K | 232,514 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 6,193 | $193.45 | $1.20M | 233,109 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 794 | $197.94 | $157.2K | 242,970 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 461 | $196.44 | $90.6K | 242,509 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 1,082 | $195.54 | $211.6K | 241,427 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 4,746 | $185.91 | $882.3K | 223,497 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 2,125 | $194.43 | $413.2K | 239,302 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2021-03-04 | 2021-03-08 | 1,633 | $185.22 | $302.5K | 221,864 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2021-02-24 | 2021-02-26 | 12,601 | — | $0 | 12,601 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2021-02-24 | 2021-02-26 | 10,437 | — | $0 | 243,764 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-11-19 | 2020-11-23 | 20,000 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-11-19 | 2020-11-23 | 5,447 | $184.69 | $1.01M | 247,880 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-11-19 | 2020-11-23 | 20,000 | $26.05 | $521.0K | 253,327 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-11-19 | 2020-11-23 | 6,300 | $186.50 | $1.17M | 234,757 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-11-19 | 2020-11-23 | 6,823 | $185.67 | $1.27M | 241,057 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-11-19 | 2020-11-23 | 1,430 | $187.60 | $268.3K | 233,327 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-09-10 | 2020-09-14 | 45,351 | — | $0 | 20,000 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-09-10 | 2020-09-14 | 11,132 | $147.68 | $1.64M | 262,690 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-09-10 | 2020-09-14 | 26,966 | $148.56 | $4.01M | 235,724 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-09-10 | 2020-09-14 | 2,397 | $149.30 | $357.9K | 233,327 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-09-10 | 2020-09-14 | 4,856 | $146.85 | $713.1K | 273,822 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-09-10 | 2020-09-14 | 45,351 | $26.05 | $1.18M | 278,678 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-05-21 | 2020-05-26 | 7,916 | — | $0 | 1 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-05-21 | 2020-05-26 | 3,086 | — | $0 | 50,154 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-05-21 | 2020-05-26 | 39,037 | — | $0 | 0 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-05-21 | 2020-05-26 | 7,916 | $16.55 | $131.0K | 238,157 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-05-21 | 2020-05-26 | 39,037 | $24.98 | $975.1K | 277,194 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-21 | 2020-05-26 | 16,496 | $139.17 | $2.30M | 260,698 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-21 | 2020-05-26 | 28,980 | $140.04 | $4.06M | 231,718 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-21 | 2020-05-26 | 1,377 | $140.99 | $194.1K | 230,341 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-05-21 | 2020-05-26 | 100 | $141.58 | $14.2K | 230,241 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-05-21 | 2020-05-26 | 3,086 | $32.40 | $100.0K | 233,327 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-04 | 2020-03-05 | 12,300 | $90.13 | $1.11M | 230,241 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-03 | 2020-03-05 | 100 | $88.56 | $8.9K | 242,541 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-03-03 | 2020-03-05 | 2,090 | $88.20 | $184.3K | 242,641 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2020-02-27 | 2020-03-02 | 18,128 | — | $0 | 18,128 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2020-02-27 | 2020-03-02 | 18,583 | — | $0 | 244,731 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-26 | 2020-02-27 | 1,881 | $86.86 | $163.4K | 227,742 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-26 | 2020-02-27 | 1,594 | $86.10 | $137.2K | 226,148 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-02-25 | 2020-02-27 | 11,735 | — | $0 | 53,240 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2020-02-25 | 2020-02-27 | 10,210 | — | $0 | 7,917 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-25 | 2020-02-27 | 1,699 | $92.34 | $156.9K | 229,449 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-02-25 | 2020-02-27 | 11,735 | $32.40 | $380.2K | 231,148 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-25 | 2020-02-27 | 1,624 | $90.22 | $146.5K | 219,413 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2020-02-25 | 2020-02-27 | 10,210 | $16.55 | $169.0K | 229,623 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2020-02-25 | 2020-02-27 | 8,412 | $91.66 | $771.0K | 221,037 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2019-09-19 | 2019-09-23 | 20,000 | — | $0 | 18,127 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-19 | 2019-09-23 | 638 | $81.82 | $52.2K | 222,375 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-19 | 2019-09-23 | 2,510 | $83.01 | $208.4K | 219,865 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-19 | 2019-09-23 | 452 | $83.72 | $37.8K | 219,413 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2019-09-19 | 2019-09-23 | 20,000 | $16.55 | $331.0K | 223,013 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 4,131 | $81.26 | $335.7K | 210,976 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 36 | $90.31 | $3.3K | 203,013 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 4,926 | $82.15 | $404.7K | 206,050 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 1,751 | $83.05 | $145.4K | 204,299 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 740 | $84.64 | $62.6K | 203,559 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 222 | $86.26 | $19.1K | 203,337 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-09-09 | 2019-09-11 | 288 | $89.27 | $25.7K | 203,049 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-03-18 | 2019-03-20 | 4,009 | $60.45 | $242.3K | 215,607 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-03-18 | 2019-03-20 | 500 | $60.91 | $30.5K | 215,107 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-03-18 | 2019-03-20 | 10,041 | $59.24 | $594.8K | 219,616 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-03-05 | 2019-03-05 | 13,000 | $58.50 | $760.5K | 229,657 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-02-28 | 2019-06-11 | 21,756 | — | $0 | 21,756 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2019-02-28 | 2019-03-04 | 21,651 | — | $0 | 21,651 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2019-02-28 | 2019-03-04 | 7,475 | $59.01 | $441.1K | 242,657 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2019-02-28 | 2019-03-04 | 22,681 | — | $0 | 250,132 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2018-09-10 | 2018-09-12 | 11,873 | — | $0 | 38,127 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2018-09-10 | 2018-09-12 | 27,566 | $57.71 | $1.59M | 227,451 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2018-09-10 | 2018-09-12 | 11,873 | $16.55 | $196.5K | 255,017 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2018-05-21 | 2018-05-22 | 16,249 | $42.53 | $691.1K | 243,144 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2018-05-09 | 2018-05-11 | 1,400 | $40.70 | $57.0K | 259,393 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2018-03-01 | 2018-03-05 | 285,563 | — | $0 | 285,563 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2018-03-01 | 2018-03-05 | 74,246 | — | $0 | 74,246 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2018-03-01 | 2018-03-05 | 147,623 | — | $0 | 260,793 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2018-03-01 | 2018-03-05 | 38,382 | — | $0 | 113,170 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2018-02-28 | 2018-03-02 | 8,825 | $34.91 | $308.1K | 74,788 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2018-01-22 | 2018-01-24 | 8,970 | $35.95 | $322.5K | 83,613 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2017-05-10 | 2017-05-11 | 2,275 | $37.97 | $86.4K | 92,583 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2017-03-01 | 2017-03-01 | 5,972 | $32.07 | $191.5K | 94,858 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2017-02-23 | 2017-03-01 | 64,975 | — | $0 | 64,975 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2017-02-23 | 2017-03-21 | 64,975 | — | $0 | 64,975 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2017-02-23 | 2017-03-01 | 32,488 | — | $0 | 100,830 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2016-11-28 | 2016-11-29 | 5,000 | $33.12 | $165.6K | 68,342 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2016-05-05 | 2016-05-09 | 1,622 | $25.71 | $41.7K | 73,342 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2016-02-29 | 2016-03-01 | 2,267 | $26.05 | $59.1K | 74,964 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2016-02-26 | 2016-03-01 | 65,351 | — | $0 | 65,351 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2016-02-26 | 2016-03-01 | 33,589 | — | $0 | 77,231 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2015-06-12 | 2015-11-12 | 1,625 | $38.46 | $62.5K | 43,642 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2015-02-26 | 2015-03-02 | 39,037 | — | $0 | 39,037 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2015-02-26 | 2015-03-02 | 20,267 | — | $0 | 45,267 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2014-05-05 | 2014-05-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2014-05-05 | 2014-05-06 | 25,000 | — | $0 | 25,000 | SEC↗ |